TOP TIERMARKET NEWSWIRE
News & sentiment

ATEA PHARMACEUTICALS (AVIR) — News & AI sentiment

ATEA PHARMACEUTICALS (AVIR) news roundup. 2 stories in the past week, 4 over 30 days. Average 30-day sentiment is 60.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 56/100
30d stories
4
avg sentiment 60.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AVIR news in the last 24 hours, 7 days, 30 days and 90 days

How much AVIR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAVIR storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days256/100AVIR headlines →
Last 30 days460.5/100AVIR headlines →
Last 90 days1960.7/100AVIR headlines →

Latest stories on AVIR

5d ago
5d ago
Aug 24
Atea (AVIR) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Aug 19
Aug 13
Aug 13
Aug 13
Aug 12
Aug 12
Aug 12
Aug 12
Aug 5
Jul 29
Jul 28
Jul 28
Jul 28
Jul 14
Jun 25
Jun 22
May 29
May 27
May 20
Open AVIR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →